Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN82643064
ISRCTN82643064
Completed
Not Applicable

Randomised controlled trial in breast cancer genetic counseling

etherlands Institute for Health Services Research (NIVEL) (The Netherlands)0 sites200 target enrollmentFebruary 26, 2007
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsGenetic counseling, web-based tailored info, communication, breast cancerCancerBreast cancer genetic counseling

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Genetic counseling, web-based tailored info, communication, breast cancer
Sponsor
etherlands Institute for Health Services Research (NIVEL) (The Netherlands)
Enrollment
200
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 26, 2007
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
etherlands Institute for Health Services Research (NIVEL) (The Netherlands)

Eligibility Criteria

Inclusion Criteria

  • •1\.Counselee for breast cancer genetic counseling
  • •2\. Age 18 or older
  • •3\. Female gender
  • •4\. Having internet access at home

Exclusion Criteria

  • •1\. Age under 18
  • •2\. Male gender
  • •3\. Not having internet access at home

Outcomes

Primary Outcomes

Not specified

Similar Trials

Withdrawn
Not Applicable
A randomised controlled trial of breast cancer patients treated with chemotherapy in a hospital day unit or at home; an analysis of cost and patient reported outcomesBreast cancerCancer - BreastPublic Health - Health service research
ACTRN12615000197538A/Prof Suzanne Robinson130
Terminated
Not Applicable
Improving access to psychological services for people with cancer: A randomised controlled trial of an interactive web-based intervention (CancerCope)
ACTRN12613001026718Griffith University490
Active, not recruiting
Phase 1
Pivotal study in breast cancer patients investigating efficacy and safety of LA-EP2006 and Neulasta®Breast CancerTherapeutic area: Diseases [C] - Cancer [C04]
EUCTR2012-002039-28-ESSandoz GmbH308
Completed
Phase 3
A study to evaluate the Efficacy and Safety of LA-EP2006 and Neulasta® in patients with breast cancer.
CTRI/2012/10/003065Sandoz GmbH302
Active, not recruiting
Phase 1
Study to see if it is possible to guide tumorectomy in case of breast cancer by near-infrared fluorescence after intravenous injection of Indocyanine GreeImaging of tumours and their margins after intravenous injection ofIndocyanine Green to breast cancer patientsTherapeutic area: Diseases [C] - Cancer [C04]
EUCTR2014-003268-19-BEJules Bordet Institute